ReP USP - Resultado da busca

Artigo de periodico
Treatment with 17 beta-estradiol protects donor heart against brain death effects in female rat (2020)
Armstrong Júnior, Roberto; Ricardo-da-Silva, Fernanda Yamamoto; Correia, Cristiano Jesus; Vidal-dos-Santos, Marina; Anunciação, Lucas Ferreira da; Silva, Raphael Santos Coutinho e; Moreira, Luiz Felipe Pinho ; Leuvenink, Hendrik Gerrit Derk; Breithaupt-Faloppa, Ana Cristina
Source: Transplant international. Unidade: FM
Subjects: MORTE CEREBRAL, ESTRADIOL, TRANSPLANTE DE CORAÇÃO, RATOS WISTAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARMSTRONG JÚNIOR, Roberto et al. Treatment with 17 beta-estradiol protects donor heart against brain death effects in female rat. Transplant international, v. 33, n. 10, p. 1312-1321, 2020Tradução . . Disponível em: https://doi.org/10.1111/tri.13687. Acesso em: 10 nov. 2024.
APA
Armstrong Júnior, R., Ricardo-da-Silva, F. Y., Correia, C. J., Vidal-dos-Santos, M., Anunciação, L. F. da, Silva, R. S. C. e, et al. (2020). Treatment with 17 beta-estradiol protects donor heart against brain death effects in female rat. Transplant international, 33( 10), 1312-1321. doi:10.1111/tri.13687
NLM
Armstrong Júnior R, Ricardo-da-Silva FY, Correia CJ, Vidal-dos-Santos M, Anunciação LF da, Silva RSC e, Moreira LFP, Leuvenink HGD, Breithaupt-Faloppa AC. Treatment with 17 beta-estradiol protects donor heart against brain death effects in female rat [Internet]. Transplant international. 2020 ; 33( 10): 1312-1321.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/tri.13687
Vancouver
Armstrong Júnior R, Ricardo-da-Silva FY, Correia CJ, Vidal-dos-Santos M, Anunciação LF da, Silva RSC e, Moreira LFP, Leuvenink HGD, Breithaupt-Faloppa AC. Treatment with 17 beta-estradiol protects donor heart against brain death effects in female rat [Internet]. Transplant international. 2020 ; 33( 10): 1312-1321.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1111/tri.13687
Artigo de periodico
Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model (2020)
Selles, Maria Clara; Fortuna, Juliana T. S; Zappa-villar, Maria F; Faria, Yasmin P. R. de; Souza, Amanda S; Suemoto, Claudia Kimie ; Leite, Renata E. P.; Rodriguez, Roberta D; Grinberg, Lea Tenenholz ; Reggiani, Paula C
Source: Molecular neurobiology. Unidade: FM
Subjects: ADENOVÍRUS, DEMÊNCIA, HIPOCAMPO, FATOR DE CRESCIMENTO INSULIN-LIKE I, MEMÓRIA, DOENÇA DE ALZHEIMER
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SELLES, Maria Clara et al. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model. Molecular neurobiology, v. 57, n. 3, p. 1473-1483, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12035-019-01827-y. Acesso em: 10 nov. 2024.
APA
Selles, M. C., Fortuna, J. T. S., Zappa-villar, M. F., Faria, Y. P. R. de, Souza, A. S., Suemoto, C. K., et al. (2020). Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model. Molecular neurobiology, 57( 3), 1473-1483. doi:10.1007/s12035-019-01827-y
NLM
Selles MC, Fortuna JTS, Zappa-villar MF, Faria YPR de, Souza AS, Suemoto CK, Leite REP, Rodriguez RD, Grinberg LT, Reggiani PC. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model [Internet]. Molecular neurobiology. 2020 ; 57( 3): 1473-1483.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12035-019-01827-y
Vancouver
Selles MC, Fortuna JTS, Zappa-villar MF, Faria YPR de, Souza AS, Suemoto CK, Leite REP, Rodriguez RD, Grinberg LT, Reggiani PC. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of A beta Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model [Internet]. Molecular neurobiology. 2020 ; 57( 3): 1473-1483.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1007/s12035-019-01827-y
Artigo de periodico
Precision non-implantable neuromodulation therapies: a perspective for the depressed brain (2020)
Borrione, Lucas; Bellini, Helena; Razza, Lais Boralli; Avila, Ana G; Baeken, Chris; Busatto Filho, Geraldo ; Gattaz, Wagner Farid ; Lotufo, Paulo Andrade ; Fraguas Junior, Renerio ; Benseñor, Isabela Judith Martins
Source: Brazilian journal of psychiatry. Unidade: FM
Assunto: DEPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORRIONE, Lucas et al. Precision non-implantable neuromodulation therapies: a perspective for the depressed brain. Brazilian journal of psychiatry, v. 42, n. 4, p. 403-419, 2020Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2019-0741. Acesso em: 10 nov. 2024.
APA
Borrione, L., Bellini, H., Razza, L. B., Avila, A. G., Baeken, C., Busatto Filho, G., et al. (2020). Precision non-implantable neuromodulation therapies: a perspective for the depressed brain. Brazilian journal of psychiatry, 42( 4), 403-419. doi:10.1590/1516-4446-2019-0741
NLM
Borrione L, Bellini H, Razza LB, Avila AG, Baeken C, Busatto Filho G, Gattaz WF, Lotufo PA, Fraguas Junior R, Benseñor IJM. Precision non-implantable neuromodulation therapies: a perspective for the depressed brain [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 4): 403-419.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0741
Vancouver
Borrione L, Bellini H, Razza LB, Avila AG, Baeken C, Busatto Filho G, Gattaz WF, Lotufo PA, Fraguas Junior R, Benseñor IJM. Precision non-implantable neuromodulation therapies: a perspective for the depressed brain [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 4): 403-419.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0741
Artigo de periodico
Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms (2020)
Serra, Mariana B; Barroso, Wermerson A; Rocha, Claudia; Furtado, Pablo G. R; Borges, Antonio C. R; Silva, Selma N; Tangerina, Marcelo M. P; Nascimento, Jessyane R. do; Barbeiro, Denise Frediani ; Souza, Heraldo Possolo de
Source: Evidence-based complementary and alternative medicine. Unidade: FM
Subjects: CICATRIZAÇÃO, CITOCINAS, COLÁGENO, EXPRESSÃO GÊNICA, INFLAMAÇÃO, FLAVONOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SERRA, Mariana B et al. Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms. Evidence-based complementary and alternative medicine, v. 2020, 2020Tradução . . Disponível em: https://doi.org/10.1155/2020/4749712. Acesso em: 10 nov. 2024.
APA
Serra, M. B., Barroso, W. A., Rocha, C., Furtado, P. G. R., Borges, A. C. R., Silva, S. N., et al. (2020). Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms. Evidence-based complementary and alternative medicine, 2020. doi:10.1155/2020/4749712
NLM
Serra MB, Barroso WA, Rocha C, Furtado PGR, Borges ACR, Silva SN, Tangerina MMP, Nascimento JR do, Barbeiro DF, Souza HP de. Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms [Internet]. Evidence-based complementary and alternative medicine. 2020 ; 2020[citado 2024 nov. 10 ] Available from: https://doi.org/10.1155/2020/4749712
Vancouver
Serra MB, Barroso WA, Rocha C, Furtado PGR, Borges ACR, Silva SN, Tangerina MMP, Nascimento JR do, Barbeiro DF, Souza HP de. Chemical Characterization and Wound Healing Property of Jacaranda decurrens Cham. (Bignoniaceae): An Experimental Study Based on Molecular Mechanisms [Internet]. Evidence-based complementary and alternative medicine. 2020 ; 2020[citado 2024 nov. 10 ] Available from: https://doi.org/10.1155/2020/4749712
Artigo de periodico
Creatine supplementation (3 g/d) and bone health in older women: a 2-year, randomized, placebo-controlled trial (2020)
Sales, Lucas Peixoto; Pinto, Ana Jessica; Rodrigues, Samara Ferrari; Alvarenga, Jackeline Couto; Goncalves, Natalia; Sampaio-Barros, Marilia M; Benatti, Fabiana Braga; Gualano, Bruno ; Pereira, Rosa Maria Rodrigues
Source: Journals of gerontology series a-biological sciences and medical sciences. Unidade: FM
Subjects: ACIDENTES POR QUEDAS, CREATINA, DENSIDADE ÓSSEA, FORÇA MUSCULAR, OSTEOPOROSE, MÉTODO DUPLO-CEGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALES, Lucas Peixoto et al. Creatine supplementation (3 g/d) and bone health in older women: a 2-year, randomized, placebo-controlled trial. Journals of gerontology series a-biological sciences and medical sciences, v. 75, n. 5, p. 931-938, 2020Tradução . . Disponível em: https://doi.org/10.1093/gerona/glz162. Acesso em: 10 nov. 2024.
APA
Sales, L. P., Pinto, A. J., Rodrigues, S. F., Alvarenga, J. C., Goncalves, N., Sampaio-Barros, M. M., et al. (2020). Creatine supplementation (3 g/d) and bone health in older women: a 2-year, randomized, placebo-controlled trial. Journals of gerontology series a-biological sciences and medical sciences, 75( 5), 931-938. doi:10.1093/gerona/glz162
NLM
Sales LP, Pinto AJ, Rodrigues SF, Alvarenga JC, Goncalves N, Sampaio-Barros MM, Benatti FB, Gualano B, Pereira RMR. Creatine supplementation (3 g/d) and bone health in older women: a 2-year, randomized, placebo-controlled trial [Internet]. Journals of gerontology series a-biological sciences and medical sciences. 2020 ; 75( 5): 931-938.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/gerona/glz162
Vancouver
Sales LP, Pinto AJ, Rodrigues SF, Alvarenga JC, Goncalves N, Sampaio-Barros MM, Benatti FB, Gualano B, Pereira RMR. Creatine supplementation (3 g/d) and bone health in older women: a 2-year, randomized, placebo-controlled trial [Internet]. Journals of gerontology series a-biological sciences and medical sciences. 2020 ; 75( 5): 931-938.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/gerona/glz162
Artigo de periodico
Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial (2020)
Brunoni, Andre Russowsky ; Carracedo, Angel; Amigo, Olalla M; Pellicer, Ana L; Talib, Leda; Carvalho, Andre F; Lotufo, Paulo Andrade ; Benseñor, Isabela Judith Martins ; Gattaz, Wagner Farid ; Cappi, Carolina
Source: Brazilian journal of psychiatry. Unidade: FM
Subjects: ANTIDEPRESSIVOS, DEPRESSÃO, MÉTODO DUPLO-CEGO, POLIMORFISMO, OXIGENASE, TERAPIA COMBINADA, TRANSFERASES, AMINAS (COMPOSTOS ORGÂNICOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, Andre Russowsky et al. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, v. 42, n. 2, p. 128-135, 2020Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2019-0620. Acesso em: 10 nov. 2024.
APA
Brunoni, A. R., Carracedo, A., Amigo, O. M., Pellicer, A. L., Talib, L., Carvalho, A. F., et al. (2020). Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial. Brazilian journal of psychiatry, 42( 2), 128-135. doi:10.1590/1516-4446-2019-0620
NLM
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0620
Vancouver
Brunoni AR, Carracedo A, Amigo OM, Pellicer AL, Talib L, Carvalho AF, Lotufo PA, Benseñor IJM, Gattaz WF, Cappi C. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 2): 128-135.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0620
Artigo de periodico
Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil (2020)
Maffazioli, Giovana D. N; Lopes, Caroline P; Heinrich-Oliveira, Vanessa; Lobo, Rogerio A; Hayashida, Sylvia A. Y; Soares Junior, Jose Maria ; Maciel, Gustavo A. R; Baracat, Edmund Chada
Source: International journal of gynecology & obstetrics. Unidade: FM
Subjects: ESTUDOS DE COORTES, OBESIDADE, SÍNDROME DO OVÁRIO POLICÍSTICO, ESTUDOS RETROSPECTIVOS, HIPERTRIGLICERIDEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAFFAZIOLI, Giovana D. N et al. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil. International journal of gynecology & obstetrics, v. 151, n. 3, p. 383-391, 2020Tradução . . Disponível em: https://doi.org/10.1002/ijgo.13374. Acesso em: 10 nov. 2024.
APA
Maffazioli, G. D. N., Lopes, C. P., Heinrich-Oliveira, V., Lobo, R. A., Hayashida, S. A. Y., Soares Junior, J. M., et al. (2020). Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil. International journal of gynecology & obstetrics, 151( 3), 383-391. doi:10.1002/ijgo.13374
NLM
Maffazioli GDN, Lopes CP, Heinrich-Oliveira V, Lobo RA, Hayashida SAY, Soares Junior JM, Maciel GAR, Baracat EC. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil [Internet]. International journal of gynecology & obstetrics. 2020 ; 151( 3): 383-391.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/ijgo.13374
Vancouver
Maffazioli GDN, Lopes CP, Heinrich-Oliveira V, Lobo RA, Hayashida SAY, Soares Junior JM, Maciel GAR, Baracat EC. Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil [Internet]. International journal of gynecology & obstetrics. 2020 ; 151( 3): 383-391.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1002/ijgo.13374
Artigo de periodico
Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort (2020)
Maison, Carolina La; Maruyama, Jessica M; Munhoz, Tiago N; Santos, Ina S; Amaral, Mariana R. do; Anselmi, Luciana; Barros, Fernando C; Pastor-Valero, Maria; Manitto, Alicia Matijasevich
Source: Brazilian journal of psychiatry. Unidade: FM
Subjects: TRANSTORNOS MENTAIS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MAISON, Carolina La et al. Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort. Brazilian journal of psychiatry, v. 42, n. 5, p. 496-502, 2020Tradução . . Disponível em: https://doi.org/10.1590/1516-4446-2019-0723. Acesso em: 10 nov. 2024.
APA
Maison, C. L., Maruyama, J. M., Munhoz, T. N., Santos, I. S., Amaral, M. R. do, Anselmi, L., et al. (2020). Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort. Brazilian journal of psychiatry, 42( 5), 496-502. doi:10.1590/1516-4446-2019-0723
NLM
Maison CL, Maruyama JM, Munhoz TN, Santos IS, Amaral MR do, Anselmi L, Barros FC, Pastor-Valero M, Manitto AM. Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 5): 496-502.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0723
Vancouver
Maison CL, Maruyama JM, Munhoz TN, Santos IS, Amaral MR do, Anselmi L, Barros FC, Pastor-Valero M, Manitto AM. Continuity of psychiatric disorders between 6 and 11 years of age in the 2004 Pelotas Birth Cohort [Internet]. Brazilian journal of psychiatry. 2020 ; 42( 5): 496-502.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1590/1516-4446-2019-0723

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies